Clin2
NCT06654700Possibly a fitNot yet recruiting

Shingles vaccine consistency study for adults 40+

Herpes Zoster

Treatments studied

Part of Infections clinical trials.

This study tests a new shingles vaccine to make sure each batch works the same way. If you are 40 or older and have never had shingles or the shingles vaccine, you may qualify.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,200 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You are 40 years old or older and a permanent resident.
  • You are generally healthy and do not have an active fever or infection on vaccination day.
  • You have never had shingles and have never been vaccinated against shingles or chickenpox.
  • You are not pregnant, breastfeeding, or planning to become pregnant in the next 12 months.
  • You do not have a weak immune system (from illness or medicine) or a history of severe allergies.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06088745Recruiting· Phase 3
Shingles vaccine trial for adults 40+

This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.

Zhenjiang, Jiangsu
NCT07354659Not yet recruiting· Phase 2
Shingles vaccine study for adults 40+

This study tests an experimental shingles vaccine in adults aged 40 and older. It aims to see if the vaccine is safe and helps your body build immunity against shingles.

NCT06801509Not yet recruiting· Phase 1/Phase 2
New shingles vaccine safety and immune response study

This study tests a new shingles vaccine for people 40 and older. It looks at safety, how well the body responds, and whether it can prevent shingles.

Dazhou, Sichuan
NCT07481604Not yet recruiting· Phase 2
Shingles vaccine trial for adults 50 and older

This trial tests a new shingles vaccine to see if it's safe and helps the body build immunity. It is for healthy adults aged 50 and older who have not had shingles before.

Daegu, Daegu
NCT07400003Recruiting· Phase 1/Phase 2
Shingles mRNA vaccine safety and immune response study

This trial tests a new mRNA vaccine to prevent shingles (herpes zoster). It checks if the vaccine is safe and helps your body build immunity. It's for adults aged 40 or older (phase 1) or 50+ (phase 2).

Xinjiang
NCT06137755Recruiting· Phase 1
Shingles vaccine study for healthy adults 50-65

This trial tests a new shingles vaccine in healthy adults aged 50 to 65. Shingles can cause a painful rash, and the vaccine aims to prevent it.

Seoul, Eunpyeong-gu

Hear when a new Herpes Zoster trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.